The Endocannabinoid System, an Underexploited and Promising Niche for the Pharmacological Treatment of Obesity and Metabolic Diseases

Overview

Journal Nutrients

Date 2022 Mar 12

PMID 35276776

Authors

Javier Gomez-Ambrosi

Affiliations

Soon will be listed here.

Abstract

Obesity represents the most prevalent metabolic disease in the world at present, posing an important public health challenge [...].

References

Tam J, Szanda G, Drori A, Liu Z, Cinar R, Kashiwaya Y . Peripheral cannabinoid-1 receptor blockade restores hypothalamic leptin signaling. Mol Metab. 2017; 6(10):1113-1125. PMC: 5641628. DOI: 10.1016/j.molmet.2017.06.010. View

DiPatrizio N . Endocannabinoids and the Gut-Brain Control of Food Intake and Obesity. Nutrients. 2021; 13(4). PMC: 8067588. DOI: 10.3390/nu13041214. View

Fruhbeck G, Gomez-Ambrosi J . Rationale for the existence of additional adipostatic hormones. FASEB J. 2001; 15(11):1996-2006. DOI: 10.1096/fj.00-0829hyp. View

Forte N, Fernandez-Rilo A, Palomba L, Di Marzo V, Cristino L . Obesity Affects the Microbiota-Gut-Brain Axis and the Regulation Thereof by Endocannabinoids and Related Mediators. Int J Mol Sci. 2020; 21(5). PMC: 7084914. DOI: 10.3390/ijms21051554. View

Bray G, Fruhbeck G, Ryan D, Wilding J . Management of obesity. Lancet. 2016; 387(10031):1947-56. DOI: 10.1016/S0140-6736(16)00271-3. View

Ye Y, El Haija M, Morgan D, Guo D, Song Y, Frank A . Endocannabinoid Receptor-1 and Sympathetic Nervous System Mediate the Beneficial Metabolic Effects of Gastric Bypass. Cell Rep. 2020; 33(4):108270. PMC: 7660289. DOI: 10.1016/j.celrep.2020.108270. View

Avalos B, Argueta D, Perez P, Wiley M, Wood C, DiPatrizio N . Cannabinoid CB Receptors in the Intestinal Epithelium Are Required for Acute Western-Diet Preferences in Mice. Nutrients. 2020; 12(9). PMC: 7551422. DOI: 10.3390/nu12092874. View

DiPatrizio N, Astarita G, Schwartz G, Li X, Piomelli D . Endocannabinoid signal in the gut controls dietary fat intake. Proc Natl Acad Sci U S A. 2011; 108(31):12904-8. PMC: 3150876. DOI: 10.1073/pnas.1104675108. View

Silvestri C, Di Marzo V . The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders. Cell Metab. 2013; 17(4):475-90. DOI: 10.1016/j.cmet.2013.03.001. View

10.

Horn H, Bohme B, Dietrich L, Koch M . Endocannabinoids in Body Weight Control. Pharmaceuticals (Basel). 2018; 11(2). PMC: 6027162. DOI: 10.3390/ph11020055. View

11.

Muller T, Bluher M, Tschop M, DiMarchi R . Anti-obesity drug discovery: advances and challenges. Nat Rev Drug Discov. 2021; 21(3):201-223. PMC: 8609996. DOI: 10.1038/s41573-021-00337-8. View

12.

DiPatrizio N, Joslin A, Jung K, Piomelli D . Endocannabinoid signaling in the gut mediates preference for dietary unsaturated fats. FASEB J. 2013; 27(6):2513-20. PMC: 3659363. DOI: 10.1096/fj.13-227587. View